Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who started this subject	5/27/2003 3:26:42 PM
From: Cacaito	Read Replies (1) of 10280

The logical buyer should be ScheringP, their pipeline is broken, their drugs going out of patent, Zetia is not building up fast, Merck is not willing to take SGP (Merck only wants Zetia)and SGP pulmonary drugs soon will go patentless. Dilution not a problem for SGP since their survival is at stake and their shares are good currency for the buyee since Shp is way down from heights. The SGP sales force will not be idle (they are not, but at least they will be able to market more in the same pitch)and the Sepr sales force could be affordably (and easily)divested.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next